Heparin-induced thrombocytopenia: a complication of thromboprophylaxis.
Heparin is a drug widely used for thromboprophylaxis or treatment in many clinical situations. However, it can cause serious adverse effects, including thrombocytopenia, which is a potentially life-threatening condition. Unfortunately, heparin-induced thrombocytopenia is generally under-recognised and under-diagnosed. A case of heparin-induced thrombocytopenia occurring in a post-operative orthopaedic patient in association with prophylactic low-molecular-weight heparin is described.
Kejariwal
D
D
Norfolk and Norwich, University Hospital, Colney Lane, Norwich NR4 7UY, UK. dkejariwal@aol.com
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D005265:Femoral Neck Fractures / Q000601:surgery; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D011183:Postoperative Complications / Q000139:chemically induced*; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight